Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093082891> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2093082891 endingPage "224" @default.
- W2093082891 startingPage "211" @default.
- W2093082891 abstract "Summary o 1. Ten per cent of adenocarcinomas present without a detectable primary. Cancer unknown primary is a clinical state in which a metastatic deposit is more apparent than its primary. 2. Cancers without a known primary may develop because o (a) metastases may occur during a prolonged clinically silent period of a neoplasm, (b) the primary neoplasm may be small or undergo actual regression, or (c) the primary may exhibit an unusual pattern of progression resulting in early dissemination. 3. Cancers of unknown primary exhibit atypical behavior. o (a) CUP primaries often originate in organs other than the expected pattern of known primaries and originate below the diaphragm 75% of the time. The most common source is pancreas, followed by cancer of the liver and stomach. (b) Twenty-five per cent of CUP cancers originate above the diaphragm. The most common sources in this location are cancers of lung and thyroid. Breast cancer is a rare cause of cancer unknown primary. 4. Cancers of unknown primary metastasize in a pattern other than that of known primaries from the same organs. 5. The philosophy of management of CUP cancers should reflect the recognition that tumors that present with metastases are incurable and that a prolonged effort devoted toward diagnosis may detract from the quality of life. Therefore, a plan of diagnostic efficiency is essential. Careful physical examination, simple bedside and laboratory investigations supplemented selectively with studies of those organs found to be abnormal by these inexpensive screening procedures is appropriate. 6. Effective palliation and, at times, prolongation and survival are achieved with aggressive treatment of breast cancer, ovarian cancer, cancer of the prostate and possibly cancer of thyroid and gastric origin. Identification of these particular neoplasms may be of particular value. 7. Initial treatment should be directed at palliation of complications of the metastases which may include pain, respiratory distress, spinal cord compression and superior vena cava syndrome. 8. If the primary is found treatment should consist of that appropriate for the particular neoplasm. To date, there is no evidence that such cancers which present with metastases are as responsive to chemotherapy, or other modalities of treatment, as are those cancers that present in a more standard manner. 9. If the primary is not found it can be treated with combination chemotherapy which should include Adriamycin, as well as conceivably 5-fluorouracil and/or Mitomycin-C. Most early studies used 5-fluorouracil as a predominating agent. However, recent investigations suggest that more aggressive treatment may increase the response rate and quality and provide more effective palliation and a more durable life. This remains to be confirmed. 10. If available, patients with carcinoma unknown primary should be entered in prospective clinical trials in an effort to determine more effective treatments for this disease. This may depend on the knowledge of predominating metastatic sites, as well as the status of hormonal receptors. 11. Recognition of the atypical features of cancer unknown primary and its consideration as a syndrome may permit earlier palliation of symptoms, shorter hospitalization and an improved quality of life for these patients who require multidisciplinary and comforting support." @default.
- W2093082891 created "2016-06-24" @default.
- W2093082891 creator A5019969198 @default.
- W2093082891 date "1981-12-01" @default.
- W2093082891 modified "2023-09-28" @default.
- W2093082891 title "The CUP syndrome (carcinoma unknown primary)" @default.
- W2093082891 cites W1970895908 @default.
- W2093082891 cites W1972415284 @default.
- W2093082891 cites W1973882455 @default.
- W2093082891 cites W1974298046 @default.
- W2093082891 cites W1974460150 @default.
- W2093082891 cites W1992615942 @default.
- W2093082891 cites W1993804393 @default.
- W2093082891 cites W1997002628 @default.
- W2093082891 cites W2034059581 @default.
- W2093082891 cites W2040634876 @default.
- W2093082891 cites W2045002811 @default.
- W2093082891 cites W2045402700 @default.
- W2093082891 cites W2046772248 @default.
- W2093082891 cites W2048189965 @default.
- W2093082891 cites W2056702278 @default.
- W2093082891 cites W2057631135 @default.
- W2093082891 cites W2059280823 @default.
- W2093082891 cites W2061164493 @default.
- W2093082891 cites W2061254867 @default.
- W2093082891 cites W2062973532 @default.
- W2093082891 cites W2066087486 @default.
- W2093082891 cites W2066415607 @default.
- W2093082891 cites W2069617048 @default.
- W2093082891 cites W2070855085 @default.
- W2093082891 cites W2082654804 @default.
- W2093082891 cites W2083832965 @default.
- W2093082891 cites W2083833046 @default.
- W2093082891 cites W2086283756 @default.
- W2093082891 cites W2089607442 @default.
- W2093082891 cites W2136621943 @default.
- W2093082891 cites W2321720090 @default.
- W2093082891 cites W2442422842 @default.
- W2093082891 cites W4211027420 @default.
- W2093082891 cites W4233224764 @default.
- W2093082891 cites W4242696368 @default.
- W2093082891 cites W4249244482 @default.
- W2093082891 cites W4251024110 @default.
- W2093082891 cites W63020733 @default.
- W2093082891 doi "https://doi.org/10.1016/s0305-7372(81)80009-6" @default.
- W2093082891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7039823" @default.
- W2093082891 hasPublicationYear "1981" @default.
- W2093082891 type Work @default.
- W2093082891 sameAs 2093082891 @default.
- W2093082891 citedByCount "41" @default.
- W2093082891 countsByYear W20930828912014 @default.
- W2093082891 countsByYear W20930828912017 @default.
- W2093082891 crossrefType "journal-article" @default.
- W2093082891 hasAuthorship W2093082891A5019969198 @default.
- W2093082891 hasConcept C121332964 @default.
- W2093082891 hasConcept C126322002 @default.
- W2093082891 hasConcept C1276947 @default.
- W2093082891 hasConcept C143998085 @default.
- W2093082891 hasConcept C2777546739 @default.
- W2093082891 hasConcept C2777977315 @default.
- W2093082891 hasConcept C71924100 @default.
- W2093082891 hasConceptScore W2093082891C121332964 @default.
- W2093082891 hasConceptScore W2093082891C126322002 @default.
- W2093082891 hasConceptScore W2093082891C1276947 @default.
- W2093082891 hasConceptScore W2093082891C143998085 @default.
- W2093082891 hasConceptScore W2093082891C2777546739 @default.
- W2093082891 hasConceptScore W2093082891C2777977315 @default.
- W2093082891 hasConceptScore W2093082891C71924100 @default.
- W2093082891 hasIssue "4" @default.
- W2093082891 hasLocation W20930828911 @default.
- W2093082891 hasLocation W20930828912 @default.
- W2093082891 hasOpenAccess W2093082891 @default.
- W2093082891 hasPrimaryLocation W20930828911 @default.
- W2093082891 hasRelatedWork W2014435840 @default.
- W2093082891 hasRelatedWork W2073133711 @default.
- W2093082891 hasRelatedWork W2123763668 @default.
- W2093082891 hasRelatedWork W2422598286 @default.
- W2093082891 hasRelatedWork W3024762421 @default.
- W2093082891 hasRelatedWork W3141825475 @default.
- W2093082891 hasRelatedWork W322223628 @default.
- W2093082891 hasRelatedWork W4230673599 @default.
- W2093082891 hasRelatedWork W4244297937 @default.
- W2093082891 hasRelatedWork W3142919920 @default.
- W2093082891 hasVolume "8" @default.
- W2093082891 isParatext "false" @default.
- W2093082891 isRetracted "false" @default.
- W2093082891 magId "2093082891" @default.
- W2093082891 workType "article" @default.